{"id":3187,"date":"2025-11-07T03:25:40","date_gmt":"2025-11-06T20:25:40","guid":{"rendered":"https:\/\/www.nanocast.cytoaurorathailand.com\/nano-casttm\/"},"modified":"2026-03-12T13:36:27","modified_gmt":"2026-03-12T06:36:27","slug":"nano-casttm","status":"publish","type":"page","link":"https:\/\/www.nanocast.cytoaurorathailand.com\/en\/nano-casttm\/","title":{"rendered":"Nano CASTTM<\/sup>"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Solve All Your Cancer Concerns with <\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
Nano CASTTM<\/sup><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

<\/span><\/span>Stop Fear with Superior Understanding<\/h3>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Nano CAST<\/span>TM\u00a0 <\/sup><\/strong>is an advanced and innovative technology designed for the detection of circulating tumor cells (CTCs) in the bloodstream. Circulating tumor cells are malignant cells that detach from primary or metastatic tumors and enter the circulatory system, where they contribute significantly to cancer progression, metastasis, and recurrence. The early identification of these cells is essential for informed clinical decision-making, timely risk assessment, preventive strategy development, and the optimization of therapeutic interventions.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/circle><\/ellipse><\/ellipse><\/circle><\/circle><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Using advanced semiconductor<\/strong> technology, Nano CAST<\/span>TM<\/sup><\/strong>\u00a0can accurately capture and count CTCs even in very low amounts in the bloodstream, providing you and your physician with valuable insights.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Screening<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Assess your cancer risk before symptoms appear<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Follow-up<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Closely monitor treatment response<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Monitoring<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Detect disease recurrence faster than ever<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

What Are Circulating Tumor Cells (CTCs)?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CTCs (Circulating Tumor Cells)<\/strong> are cancer cells that have directly detached from a tumor and circulate in the bloodstream, acting like \u201cseeds\u201d ready to grow and spread to other organs.
In contrast, ctDNA (circulating tumor DNA)<\/strong> consists of fragments of DNA from dead cancer cells. Detecting CTCs provides more complete and meaningful information for treatment planning than ctDNA alone.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t